OCT4 induces embryonic pluripotency via STAT3 signaling and metabolic mechanisms
OCT4 is a fundamental component of the molecular circuitry governing pluripotency in vivo and in vitro. To determine how OCT4 establishes and protects the pluripotent lineage in the embryo, we used comparative single-cell transcriptomics and quantitative immunofluorescence on control and OCT4 null b...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 118; no. 3; pp. 1 - 11 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
19.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | OCT4 is a fundamental component of the molecular circuitry governing pluripotency in vivo and in vitro. To determine how OCT4 establishes and protects the pluripotent lineage in the embryo, we used comparative single-cell transcriptomics and quantitative immunofluorescence on control and OCT4 null blastocyst inner cell masses at two developmental stages. Surprisingly, activation of most pluripotency-associated transcription factors in the early mouse embryo occurs independently of OCT4, with the exception of the JAK/STAT signaling machinery. Concurrently, OCT4 null inner cell masses ectopically activate a subset of trophectoderm- associated genes. Inspection of metabolic pathways implicates the regulation of rate-limiting glycolytic enzymes by OCT4, consistent with a role in sustaining glycolysis. Furthermore, up-regulation of the lysosomal pathway was specifically detected in OCT4 null embryos. This finding implicates a requirement for OCT4 in the production of normal trophectoderm. Collectively, our findings uncover regulation of cellular metabolism and biophysical properties as mechanisms by which OCT4 instructs pluripotency. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by Rudolf Jaenisch, Whitehead Institute for Biomedical Research, Cambridge, MA, and approved December 8, 2020 (received for review June 3, 2020) 1G.G.S. and A.K. contributed equally to this work. Author contributions: G.G.S., A.K., and J.N. designed research; A.K., A.Y., L.E.B., S.E.S., S.H., H.T.S., T.E.B., J.C.R.S., and J.N. performed research; G.G.S., A.Y., L.E.B., S.E.S., and J.N. contributed new reagents/analytic tools; G.G.S., A.K., L.E.B., S.E.S., and J.N. analyzed data; and G.G.S., A.K., and J.N. wrote the paper. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.2008890118 |